19.06.2013 Views

INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA

INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA

INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CAPÍTULO IV<br />

116<br />

TABLE 3. Clinical characteristics of high and low sRAGE patients groups<br />

Variables<br />

Low sRAGE<br />

(1220 pg/mL)<br />

(n = 30)<br />

p value<br />

DEMOGRAPHIC FACTORS<br />

Age (years) 68.9 ± 1.4 71.30 ± 1.8 0.370<br />

Sex (male/female) 67.1 % / 32.9 % 63.3 % / 36.7 % 0.712<br />

Medium blood pressure (mmHg) 94.6 ± 1.7 93.9 ± 2.7 0.815<br />

IMC (kg/m 2 ) 28.5 ± 0.6 27.4 ± 1.2 0.360<br />

CARDIOVASCULAR RISK FACTORS<br />

Arterial Hypertension 65.8 % 60.0 % 0.580<br />

Hyperlipidemia 62.5 % 56.7 % 0.582<br />

Diabetes mellitus 35.6 % 36.7 % 0.920<br />

Smokers 8.2 % 6.7 %<br />

Ex-smokers 34.2 % 26.7 %<br />

ISCHEMIC ETIOLOGY AND SEVERITY<br />

0.690<br />

Ischemic 21.9 % 50.0 % 0.005<br />

One damaged vessel<br />

Two damaged vessels<br />

Three damaged vessels<br />

NYHA I<br />

NYHA II<br />

NYHA III<br />

68.8 %<br />

18.8 %<br />

12.5 %<br />

FUNCTIONAL CLASS (NYHA)<br />

17.4 %<br />

66.7 %<br />

15.9 %<br />

6.70 %<br />

53.3 %<br />

40.0 %<br />

3.3 %<br />

63.3 %<br />

33.3 %<br />

0.002<br />

0.046<br />

EKG<br />

Rhythm (sinusal/non) 70.8 % / 29.2 % 33.3 % / 66.7 % 0.001<br />

ECHOCARDIOGRAPHY<br />

Depressed LVEF 77.5 % 72.4 % 0.592<br />

Left ventricular hipertrophy 52.5 % 44.4 % 0.322<br />

Left ventricular dilatation 60.3 % 66.7 % 0.643<br />

Left atrial dilatation 84.4 % 100 % 0.029<br />

ANALITIC PARAMETERS<br />

Glucose (mg/dL) 116.6 ± 3.6 133.6 ± 12.0 0.185<br />

Fructosamine (mg/dL) 248.5 ± 14.4 289.9 ± 16.9 0.106<br />

Glycated haemoglobin (%) 6.5 ± 0.2 7.0 ± 0.3 0.178<br />

Glycated albumin (ng/mL) 21.3 ± 1.5 21.25 ± 1.84 0.964<br />

Fluorescent AGEs (AU) 63.1 ± 2.3 71.52 ± 3.97 0.061<br />

Haemoglobin (g/dL) 13.5 ± 0.2 12.5 ± 0.23 0.002<br />

Creatinine (mg/dL) 1.10 ± 0.03 1.18 ± 0.06 0.179<br />

Estimated glomerular filtrate (ml/min) 61.51 ± 2.15 52.50 ± 2.77 0.054<br />

Cystatine (mg/L) 0.98 ± 0.05 1.19 ± 0.10 0.020<br />

NTproBNP > 400 pg/mL 75.4% 100% 0.009<br />

LDL (mg/dL) 112.83 ± 3.73 108.53 ± 8.05 0.581<br />

HDL (mg/dL) 44.63 ± 2.42 43.18 ± 3.34 0.738<br />

Triglicerides (mg/dL) 120.01 ± 7.57 104.32 ± 10.80 0.262<br />

TREATMENT<br />

B-blockers 89.0 % 80.0 % 0.224<br />

ACE inhibitors/ARA 93.2 % 96.7 % 0.778<br />

Espironolactone 61.6 % 70.0 % 0.422<br />

Diuretics 79.5 % 83.3 % 0.218<br />

Antiplatelets 46.6 % 30.0 % 0.618<br />

Nitrates 12.2 % 26.7 % 0.075<br />

Statins 45.2 % 50.0 % 0.658<br />

Oral antidiabetic drugs 28.8 % 20.0 % 0.358<br />

Insulin 6.8 % 16.7 % 0.126<br />

Abbreviations as in Table 1

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!